James M. Harrington , Donna S. Seibert , Glenn Williams , Thanh Nguyen , Denise McClenathan , Stephen W. Erickson
{"title":"The Product Quality Research Institute elemental impurity interlaboratory study: Results and implications for industry","authors":"James M. Harrington , Donna S. Seibert , Glenn Williams , Thanh Nguyen , Denise McClenathan , Stephen W. Erickson","doi":"10.1016/j.jtemin.2025.100227","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Pharmaceutical laboratories experienced a paradigm shift in drug product elemental impurity (EI) expectations in International Council on Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) Guideline Q3D and United States Pharmacopeia (USP) General Chapters <232>/<233>. These guidelines describe a risk-based approach to EI analysis. Few systematic evaluations of interlaboratory performance on EI analysis in pharmaceutics have been conducted following these guidelines. Our goal is to address key technical challenges faced by laboratories during the implementation of these regulations.</div></div><div><h3>Materials and Methods</h3><div>We organized an interlaboratory study using standardized samples and methodology to assess sample preparation and analysis variability. Participants performed microwave-assisted acid preparation of simulated pharmaceutical products and analyzed Class 1 and 2A EI's by inductively-coupled plasma-mass spectrometry (ICP-MS). Several laboratories performed X-ray Fluorescence spectroscopy (XRF) for comparison.</div></div><div><h3>Results</h3><div>ICP-MS reproducibility was high both within and between laboratories, except for Hg and V. Exhaustive extraction and total digestion were generally comparable, between 87 and 111 % for As, Cd, Co, and Pb. Total digestion exhibited lower variability than exhaustive extraction. Two types of microwave systems produced comparable results for most elements except Hg and Pb. The summation approach was comparable to direct analysis of tablets except for Hg and Cd, but summation demonstrated greater variability. XRF showed good agreement with ICP-MS and low replicate variability within labs.</div></div><div><h3>Discussion and Conclusions</h3><div>While the results were generally favorable, they demonstrate that some technical challenges remain to be addressed related to standardizing laboratory practices including interference correction strategies and selection of preparation methods. We discuss implications for method transfer between laboratories.</div></div>","PeriodicalId":73997,"journal":{"name":"Journal of trace elements and minerals","volume":"12 ","pages":"Article 100227"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of trace elements and minerals","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2773050625000187","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Pharmaceutical laboratories experienced a paradigm shift in drug product elemental impurity (EI) expectations in International Council on Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) Guideline Q3D and United States Pharmacopeia (USP) General Chapters <232>/<233>. These guidelines describe a risk-based approach to EI analysis. Few systematic evaluations of interlaboratory performance on EI analysis in pharmaceutics have been conducted following these guidelines. Our goal is to address key technical challenges faced by laboratories during the implementation of these regulations.
Materials and Methods
We organized an interlaboratory study using standardized samples and methodology to assess sample preparation and analysis variability. Participants performed microwave-assisted acid preparation of simulated pharmaceutical products and analyzed Class 1 and 2A EI's by inductively-coupled plasma-mass spectrometry (ICP-MS). Several laboratories performed X-ray Fluorescence spectroscopy (XRF) for comparison.
Results
ICP-MS reproducibility was high both within and between laboratories, except for Hg and V. Exhaustive extraction and total digestion were generally comparable, between 87 and 111 % for As, Cd, Co, and Pb. Total digestion exhibited lower variability than exhaustive extraction. Two types of microwave systems produced comparable results for most elements except Hg and Pb. The summation approach was comparable to direct analysis of tablets except for Hg and Cd, but summation demonstrated greater variability. XRF showed good agreement with ICP-MS and low replicate variability within labs.
Discussion and Conclusions
While the results were generally favorable, they demonstrate that some technical challenges remain to be addressed related to standardizing laboratory practices including interference correction strategies and selection of preparation methods. We discuss implications for method transfer between laboratories.
Journal of trace elements and mineralsMedicine and Dentistry (General), Analytical Chemistry, Environmental Science (General), Toxicology, Biochemistry, Genetics and Molecular Biology (General), Nutrition, Veterinary Science and Veterinary Medicine (General)